Heron Therapeutics is trading at $0.30 (-10.01%), with broader risk-off trading coinciding with oil-price gains amid Strait of Hormuz tensions.
- No company-specific announcement for October 22, 2026, was identified; the investor-relations page lists its August 10 second-quarter results as the latest release.
- Major U.S. indices were also lower, consistent with a broad-market explanation.